Left ventricular hypertrophy (LVH) is a manifestation of uncontrolled arterial hypertension. It is an adverse marker of target end-organ damage, predictive of cardiovascular morbidity and mortality. 1 ...

To assess renin, aldosterone, human atrial natriuretic peptide (hANP) and brain natriuretic peptide (BNP) levels in cord blood from monochorionic diamniotic (MD) twins with a birthweight (BW) ...

AnaSpec, EGT Group provides a wide range of GO® (catalog) natriuretic peptides for use in research laboratories. Our selection of atrial natriuretic peptides (ANPs) include the biologically active ...

ANP, BNP, and CNP are proving to be reliable biomarkers for a variety of conditions. Natriuretic peptides mainly consist of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and ...

NT-proBNP drop by >10% before hospital discharge NT-proBNP at discharge or at 2 weeks' follow-up Clinical judgment 1.9 years (median) Hospitalization-free survival Abbreviations: BNP, B-type ...

The natriuretic peptides are a family of related hormones that play a crucial role in cardiovascular homeostasis. They have recently emerged as potentially important clinical markers in heart failure.

The natriuretic peptides are counterregulatory hormones involved in volume homeostasis and cardiovascular remodeling. The prognostic significance of plasma natriuretic peptide levels in apparently ...

Millions of adults have atrial fibrillation—an irregular beating of the upper chambers of the heart that yields increased risk of heart failure, stroke and death. Many genetic mutations in the ...

Atrial natriuretic peptide (ANP) is similar to b-type natriuretic peptide (BNP) in the hemodynamic effects. ANP is not measured clinically unlike BNP. It is released in response to myocyte stretch ...

B-type natriuretic peptide is released by cardiac myocytes in response to wall stretch. There are many hemodynamic effects of BNP which are beneficial in the setting of decompensated congestive heart ...

SAN FRANCISCO — At face value, the randomized REMINDER trial [1] suggests that starting an aldosterone blocker like eplerenone (Inspra, Pfizer) within the first day after an acute MI in patients ...